BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 17349891)

  • 1. Dimethylarginine dimethylaminohydrolase promotes endothelial repair after vascular injury.
    Konishi H; Sydow K; Cooke JP
    J Am Coll Cardiol; 2007 Mar; 49(10):1099-105. PubMed ID: 17349891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of dimethylarginine dimethylaminohydrolase inhibits asymmetric dimethylarginine-induced endothelial dysfunction in the cerebral circulation.
    Dayoub H; Rodionov RN; Lynch C; Cooke JP; Arning E; Bottiglieri T; Lentz SR; Faraci FM
    Stroke; 2008 Jan; 39(1):180-4. PubMed ID: 18063827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of dimethylarginine dimethylaminohydrolase reduces tissue asymmetric dimethylarginine levels and enhances angiogenesis.
    Jacobi J; Sydow K; von Degenfeld G; Zhang Y; Dayoub H; Wang B; Patterson AJ; Kimoto M; Blau HM; Cooke JP
    Circulation; 2005 Mar; 111(11):1431-8. PubMed ID: 15781754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dimethylarginine dimethylaminohydrolase overexpression suppresses graft coronary artery disease.
    Tanaka M; Sydow K; Gunawan F; Jacobi J; Tsao PS; Robbins RC; Cooke JP
    Circulation; 2005 Sep; 112(11):1549-56. PubMed ID: 16144995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dimethylarginine dimethylaminohydrolase regulates nitric oxide synthesis: genetic and physiological evidence.
    Dayoub H; Achan V; Adimoolam S; Jacobi J; Stuehlinger MC; Wang BY; Tsao PS; Kimoto M; Vallance P; Patterson AJ; Cooke JP
    Circulation; 2003 Dec; 108(24):3042-7. PubMed ID: 14638548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitric oxide upregulates dimethylarginine dimethylaminohydrolase-2 via cyclic GMP induction in endothelial cells.
    Sakurada M; Shichiri M; Imamura M; Azuma H; Hirata Y
    Hypertension; 2008 Nov; 52(5):903-9. PubMed ID: 18824664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preservation of vascular DDAH activity contributes to the protection of captopril against endothelial dysfunction in hyperlipidemic rabbits.
    Lin Y; Feng M; Lu CW; Lei YP; He ZM; Xiong Y
    Eur J Pharmacol; 2017 Mar; 798():43-48. PubMed ID: 28163022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of DDAH/ADMA/NOS pathway in nicotine-induced endothelial dysfunction.
    Jiang DJ; Jia SJ; Yan J; Zhou Z; Yuan Q; Li YJ
    Biochem Biophys Res Commun; 2006 Oct; 349(2):683-93. PubMed ID: 16959216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asymmetric dimethyl L-arginine (ADMA) is a critical regulator of myocardial reperfusion injury.
    Stühlinger MC; Conci E; Haubner BJ; Stocker EM; Schwaighofer J; Cooke JP; Tsao PS; Pachinger O; Metzler B
    Cardiovasc Res; 2007 Jul; 75(2):417-25. PubMed ID: 17559823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelium is the organ chiefly responsible for the catabolism of plasma asymmetric dimethylarginine--an explanation for the elevation of plasma ADMA in disorders characterized by endothelial dysfunction.
    McCarty MF
    Med Hypotheses; 2004; 63(4):699-708. PubMed ID: 15325021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene transfer of dimethylarginine dimethylaminohydrolase-2 improves the impairments of DDAH/ADMA/NOS/NO pathway in endothelial cells induced by lysophosphatidylcholine.
    Feng M; Liu L; Guo Z; Xiong Y
    Eur J Pharmacol; 2008 Apr; 584(1):49-56. PubMed ID: 18342305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dimethylarginine dimethylaminohydrolase-1 (DDAH1) is frequently upregulated in prostate cancer, and its overexpression conveys tumor growth and angiogenesis by metabolizing asymmetric dimethylarginine (ADMA).
    Reddy KRK; Dasari C; Duscharla D; Supriya B; Ram NS; Surekha MV; Kumar JM; Ummanni R
    Angiogenesis; 2018 Feb; 21(1):79-94. PubMed ID: 29150732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dimethylarginine dimethylaminohydrolase inhibition and asymmetric dimethylarginine accumulation contribute to endothelial dysfunction in rats exposed to glycosylated protein: effects of aminoguanidine.
    Yin QF; Fu SH; He P; Xiong Y
    Atherosclerosis; 2007 Jan; 190(1):53-61. PubMed ID: 16533509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dimethylarginine dimethylaminohydrolase-2 overexpression improves impaired nitric oxide synthesis of endothelial cells induced by glycated protein.
    Lu CW; Xiong Y; He P
    Nitric Oxide; 2007 Feb; 16(1):94-103. PubMed ID: 16979918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Taurine protects against low-density lipoprotein-induced endothelial dysfunction by the DDAH/ADMA pathway.
    Tan B; Jiang DJ; Huang H; Jia SJ; Jiang JL; Hu CP; Li YJ
    Vascul Pharmacol; 2007 May; 46(5):338-45. PubMed ID: 17293168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pioglitazone lowers systemic asymmetric dimethylarginine by inducing dimethylarginine dimethylaminohydrolase in rats.
    Wakino S; Hayashi K; Tatematsu S; Hasegawa K; Takamatsu I; Kanda T; Homma K; Yoshioka K; Sugano N; Saruta T
    Hypertens Res; 2005 Mar; 28(3):255-62. PubMed ID: 16097370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of dimethylarginine dimethylaminohydrolases in the regulation of endothelial nitric oxide production.
    Pope AJ; Karrupiah K; Kearns PN; Xia Y; Cardounel AJ
    J Biol Chem; 2009 Dec; 284(51):35338-47. PubMed ID: 19820234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of asymmetric dimethylarginine in vascular injury in transgenic mice overexpressing dimethylarginie dimethylaminohydrolase 2.
    Hasegawa K; Wakino S; Tatematsu S; Yoshioka K; Homma K; Sugano N; Kimoto M; Hayashi K; Itoh H
    Circ Res; 2007 Jul; 101(2):e2-10. PubMed ID: 17601800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorylation of Nonmuscle Myosin Light Chain Promotes Endothelial Injury in Hyperlipidemic Rats Through a Mechanism Involving Downregulation of Dimethylarginine Dimethylaminohydrolase 2.
    Wu Y; Zhang JJ; Li TB; Liu WQ; Li LS; Luo XJ; Jiang JL; Ma QL; Yang ZC; Peng J
    J Cardiovasc Pharmacol Ther; 2016 Nov; 21(6):536-548. PubMed ID: 26911182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human recombinant erythropoietin augments serum asymmetric dimethylarginine concentrations but does not compromise nitric oxide generation in mice.
    Desai A; Zhao Y; Warren JS
    Nephrol Dial Transplant; 2008 May; 23(5):1513-20. PubMed ID: 18204093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.